speb/financial-data huggingface dataset:
CVS.DE income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 787000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Inventory: 19246000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Inventory: 19246000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Invested Capital: 139784000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Invested Capital: 139784000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Investing Cash Flow: -5871000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -1998000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 28097000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 28097000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Investments And Advances: 32669000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 32669000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Issuance Of Debt: 3969000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
CVS.DE balance_sheet (annual, 2025-12-31) — Land And Improvements: 1809000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 1809000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Leases: 6812000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Leases: 6812000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 13643000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 13643000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Long Term Debt: 60502000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 60502000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 74145000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 74145000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 3969000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
CVS.DE cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -3629000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -20000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 24613000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 24613000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Minority Interest: 168000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Minority Interest: 168000000.00
CVS.DE income_statement (annual, 2025-12-31) — Minority Interests: 40000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Minority Interests: 20000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -436000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -7000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 0.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
CVS.DE balance_sheet (annual, 2025-12-31) — Net Debt: 56117000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Net Debt: 56117000000.00
CVS.DE income_statement (annual, 2025-12-31) — Net Income: 1768000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Net Income: 2943000000.00
CVS.DE income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 1768000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 2943000000.00
CVS.DE income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 1728000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 2923000000.00
CVS.DE income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 1768000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 2943000000.00
CVS.DE income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 1768000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 2943000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 1728000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 2923000000.00
CVS.DE income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 1728000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 2923000000.00
CVS.DE income_statement (annual, 2025-12-31) — Net Interest Income: -3119000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Net Interest Income: -787000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -2629000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -1224000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -1779000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -1267000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 340000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -20000000.00
CVS.DE income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -3119000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -787000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -158000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -6000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 26000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 17000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Net PPE: 28056000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Net PPE: 28056000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -2832000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -784000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: -2119000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: -1247000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -35772000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -35772000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 3832000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 3832000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 3832000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 3832000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 1994000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 1994000000.00
CVS.DE income_statement (annual, 2025-12-31) — Normalized EBITDA: 15103000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 3288000000.00
CVS.DE income_statement (annual, 2025-12-31) — Normalized Income: 6008778000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Normalized Income: 2943000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Operating Cash Flow: 10639000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 3390000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Operating Gains Losses: -247000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 0.00
CVS.DE income_statement (annual, 2025-12-31) — Operating Income: 10385000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Operating Income: 2112000000.00
CVS.DE income_statement (annual, 2025-12-31) — Operating Revenue: 402067000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Operating Revenue: 105693000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 1271000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 1271000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Other Current Assets: 5091000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 5091000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 4068000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 4068000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 1116000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 1116000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 406000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 406000000.00
CVS.DE income_statement (annual, 2025-12-31) — Other Income Expense: -5130000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Other Income Expense: 29000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 25508000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 25508000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Other Investments: 4572000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Other Investments: 4572000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Other Non Cash Items: -336000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 5119000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 5119000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 9493000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 9493000000.00
CVS.DE income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 112000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 29000000.00
CVS.DE income_statement (annual, 2025-12-31) — Other Operating Expenses: 44977000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 11455000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Other Payable: 41743000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Other Payable: 41743000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Other Properties: 14973000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Other Properties: 14973000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Other Receivables: 23463000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Other Receivables: 23463000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 2145000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 2145000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Payables: 59384000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Payables: 59384000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 81771000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 81771000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
CVS.DE income_statement (annual, 2025-12-31) — Pretax Income: 2136000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Pretax Income: 1354000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 394000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 86000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Properties: 0.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CVS.DE cash_flow (annual, 2025-12-31) — Purchase Of Business: -436000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -7000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Purchase Of Investment: -15012000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -3967000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Purchase Of PPE: -2832000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -784000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Receivables: 39779000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Receivables: 39779000000.00
CVS.DE income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 346705000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 92126000000.00
CVS.DE income_statement (annual, 2025-12-31) — Reconciled Depreciation: 4606000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 1147000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Repayment Of Debt: -5748000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -1267000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: 0.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: 0.00
CVS.DE income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 0.00
CVS.DE income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 0.00
CVS.DE balance_sheet (annual, 2025-12-31) — Retained Earnings: 61196000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 61196000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Sale Of Investment: 12383000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 2743000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Share Issued: 1787000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Share Issued: 1787000000.00
CVS.DE cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 0.00
CVS.DE cash_flow (annual, 2025-12-31) — Short Term Debt Payments: -2119000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Short Term Debt Payments: -1247000000.00
CVS.DE income_statement (annual, 2025-12-31) — Special Income Charges: -5242000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
CVS.DE cash_flow (annual, 2025-12-31) — Stock Based Compensation: 535000000.00
CVS.DE cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 135000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Stockholders Equity: 75214000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 75214000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Tangible Book Value: -35772000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -35772000000.00
CVS.DE income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -1001222000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CVS.DE income_statement (annual, 2025-12-31) — Tax Provision: 408000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Tax Provision: -1569000000.00
CVS.DE income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.19
CVS.DE income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
CVS.DE balance_sheet (annual, 2025-12-31) — Total Assets: 253538000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Total Assets: 253538000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Total Capitalization: 135716000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 135716000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Total Debt: 79950000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Total Debt: 79950000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 75382000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 75382000000.00
CVS.DE income_statement (annual, 2025-12-31) — Total Expenses: 391682000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Total Expenses: 103581000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 178156000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 178156000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 178824000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 178824000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 89464000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 89464000000.00
CVS.DE income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 4660000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 2112000000.00
CVS.DE income_statement (annual, 2025-12-31) — Total Unusual Items: -5242000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
CVS.DE income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -5242000000.00
CVS.DE income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CVS.DE balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 516000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 516000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Treasury Stock: 36790000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 36790000000.00
CVS.DE balance_sheet (annual, 2025-12-31) — Working Capital: -13978000000.00
CVS.DE balance_sheet (quarterly, 2025-12-31) — Working Capital: -13978000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — +Operating Expense: 10944000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — +Total Revenue: 100426000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 16922000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 20144000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 26287000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — Basic Average Shares: 1273000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — Basic EPS: 2.31
CVS.DE cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 8712000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -849000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 15234000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Capital Stock: 50679000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 9542000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 11802000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -847000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -2318000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -874000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 4249000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -562000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Change In Inventory: 1476000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 479000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -196000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Change In Payable: -552000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -552000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Change In Receivables: -1205000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 2000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -1205000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Changes In Cash: 1057000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Common Stock: 50679000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -847000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 77456000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 84802000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 22258000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Current Assets: 74817000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 1904000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Current Debt: 2580000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 4484000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 86406000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -91000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Deferred Tax: -91000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 1115000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 1115000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 1279000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — Diluted EPS: 2.30
CVS.DE income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 2943000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — EBIT: 4712000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — EBITDA: 5827000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — End Cash Position: 9769000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -2318000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 3400000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of Business: 0.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 201000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Goodwill: 85478000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 110548000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Gross PPE: 27778000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — Gross Profit: 15624000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Held To Maturity Securities: 1339000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — Interest Expense: 774000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 774000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Inventory: 17770000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Invested Capital: 140567000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -874000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 27626000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 32407000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 13330000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 60531000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 73861000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -1518000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Minority Interest: 181000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — Minority Interests: -14000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -5000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Net Debt: 53569000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — Net Income: 2943000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 2943000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 2957000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 2943000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 2943000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 2957000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 2957000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — Net Interest Income: -774000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -27000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -1518000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -1518000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -774000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -56000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 7000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Net PPE: 27778000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -849000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: 0.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -33092000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 3771000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 3771000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 5827000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — Normalized Income: 2943000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 4249000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — Operating Income: 4680000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — Operating Revenue: 100426000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 1273000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 4253000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 2580000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 1075000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 201000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — Other Income Expense: 32000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 25070000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Other Investments: 4781000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 7424000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 11299000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 32000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 10944000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Other Payable: 41667000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Other Properties: 27778000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Other Receivables: 20848000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 2260000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Payables: 58589000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 80847000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
CVS.DE income_statement (quarterly, 2026-03-31) — Pretax Income: 3938000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 103000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -5000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -4186000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -849000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Receivables: 40992000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 84802000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 1115000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -1518000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 63282000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 4159000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Share Issued: 1788000000.00
CVS.DE cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 266000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 77456000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -33092000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CVS.DE income_statement (quarterly, 2026-03-31) — Tax Provision: 981000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.25
CVS.DE balance_sheet (quarterly, 2026-03-31) — Total Assets: 252974000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 137987000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Total Debt: 78345000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 77637000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — Total Expenses: 95746000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 175337000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 178157000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 88931000000.00
CVS.DE income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 4680000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 515000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 36706000000.00
CVS.DE balance_sheet (quarterly, 2026-03-31) — Working Capital: -11589000000.00
CVS.TO balance_sheet (annual, 2021-12-31) — Assets Held For Sale Current: 0.00
CVS.TO income_statement (annual, 2021-12-31) — Net Income Discontinuous Operations: 0.00
CVS.TO income_statement (annual, 2021-12-31) — Other Special Charges: 452000000.00
CVS.TO cash_flow (annual, 2021-12-31) — Sale Of Business: 0.00
CVS.TO cash_flow (annual, 2021-12-31) — Sale Of PPE: 0.00
CVS.TO income_statement (annual, 2022-12-31) — +Operating Expense: 38212000000.00
CVS.TO income_statement (annual, 2022-12-31) — +Total Revenue: 322467000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Accounts Payable: 14838000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Accounts Receivable: 11659000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -21483000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 0.00
CVS.TO balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 908000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 17562000000.00
CVS.TO income_statement (annual, 2022-12-31) — Basic Average Shares: 7205973356.00
CVS.TO income_statement (annual, 2022-12-31) — Basic EPS: 0.60
CVS.TO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 12691000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 4545000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Capital Expenditure: -2727000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 18478000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Capital Stock: 48193000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 12945000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 15723000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -2907000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -10516000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -5047000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 16177000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Change In Account Payable: 4260000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Change In Inventory: -1435000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -491000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 6463000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Change In Payable: 5252000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 5252000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Change In Receivables: -2971000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Change In Working Capital: 6818000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -2971000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Changes In Cash: 614000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Commercial Paper: 0.00
CVS.TO balance_sheet (annual, 2022-12-31) — Common Stock: 48193000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -2907000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 71469000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Common Stock Payments: -3500000000.00
CVS.TO income_statement (annual, 2022-12-31) — Cost Of Revenue: 267965000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 18745000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Current Assets: 65633000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 1678000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Current Debt: 1778000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 3456000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Current Liabilities: 69421000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Deferred Income Tax: -2029000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Deferred Tax: -2029000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Defined Pension Benefit: 3228000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 4224000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 4224000000.00
CVS.TO income_statement (annual, 2022-12-31) — Diluted Average Shares: 7266389292.00
CVS.TO income_statement (annual, 2022-12-31) — Diluted EPS: 0.59
CVS.TO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 4311000000.00
CVS.TO income_statement (annual, 2022-12-31) — EBIT: 8123000000.00
CVS.TO income_statement (annual, 2022-12-31) — EBITDA: 12347000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Employee Benefits: 3228000000.00
CVS.TO cash_flow (annual, 2022-12-31) — End Cash Position: 13305000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Financing Cash Flow: -10516000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Free Cash Flow: 13450000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: -475000000.00
CVS.TO income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: -2533000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -1264000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Goodwill: 78150000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 102953000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Gross PPE: 52228000000.00
CVS.TO income_statement (annual, 2022-12-31) — Gross Profit: 54502000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Held To Maturity Securities: 989000000.00
CVS.TO income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 0.00
CVS.TO income_statement (annual, 2022-12-31) — Interest Expense: 2287000000.00
CVS.TO income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 2287000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Inventories Adjustments Allowances: -559000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Inventory: 19090000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Invested Capital: 123723000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -5047000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 18551000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Investments And Advances: 21096000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
CVS.TO balance_sheet (annual, 2022-12-31) — Land And Improvements: 1996000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Leases: 6238000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 16800000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Long Term Debt: 50476000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 67276000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
CVS.TO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -4211000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 21821000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Minority Interest: 300000000.00
CVS.TO income_statement (annual, 2022-12-31) — Minority Interests: -16000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -1388000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -3500000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Net Debt: 39309000000.00
CVS.TO income_statement (annual, 2022-12-31) — Net Income: 4311000000.00
CVS.TO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 4311000000.00
CVS.TO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 4327000000.00
CVS.TO income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: 0.00
CVS.TO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 4311000000.00
CVS.TO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 4311000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 4327000000.00
CVS.TO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 4327000000.00
CVS.TO income_statement (annual, 2022-12-31) — Net Interest Income: -2287000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -1017000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -4211000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -4211000000.00
CVS.TO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -2287000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -449000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 85000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Net PPE: 30745000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -2727000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 0.00
CVS.TO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -31484000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 4016000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 4016000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 3228000000.00
CVS.TO income_statement (annual, 2022-12-31) — Normalized EBITDA: 20683000000.00
CVS.TO income_statement (annual, 2022-12-31) — Normalized Income: 10487976000.00
CVS.TO cash_flow (annual, 2022-12-31) — Operating Cash Flow: 16177000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Operating Gains Losses: 2058000000.00
CVS.TO income_statement (annual, 2022-12-31) — Operating Income: 16290000000.00
CVS.TO income_statement (annual, 2022-12-31) — Operating Revenue: 322467000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 1300000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Other Current Assets: 2636000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 1778000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 2817000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -1264000000.00
CVS.TO income_statement (annual, 2022-12-31) — Other Income Expense: -8167000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 24803000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Other Inventories: 19649000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Other Investments: 2545000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Other Non Cash Items: 332000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 4620000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 12565000000.00
CVS.TO income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 169000000.00
CVS.TO income_statement (annual, 2022-12-31) — Other Operating Expenses: 38212000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Other Payable: 29565000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Other Properties: 17628000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Other Receivables: 15617000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 2778000000.00
CVS.TO income_statement (annual, 2022-12-31) — Other Special Charges: 5803000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Payables: 44403000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 63148000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
CVS.TO income_statement (annual, 2022-12-31) — Pretax Income: 5836000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 551000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Properties: 0.00
CVS.TO cash_flow (annual, 2022-12-31) — Purchase Of Business: -1388000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Purchase Of Investment: -7746000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -2727000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Receivables: 27276000000.00
CVS.TO income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 267965000000.00
CVS.TO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 4224000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Repayment Of Debt: -4211000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -3500000000.00
CVS.TO income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 0.00
CVS.TO balance_sheet (annual, 2022-12-31) — Retained Earnings: 56398000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Sale Of Investment: 6729000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Sale Of PPE: 0.00
CVS.TO balance_sheet (annual, 2022-12-31) — Share Issued: 1758000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 0.00
CVS.TO cash_flow (annual, 2022-12-31) — Short Term Debt Payments: 0.00
CVS.TO income_statement (annual, 2022-12-31) — Special Income Charges: -8336000000.00
CVS.TO cash_flow (annual, 2022-12-31) — Stock Based Compensation: 447000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 71469000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Tangible Book Value: -31484000000.00
CVS.TO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -2159024000.00
CVS.TO income_statement (annual, 2022-12-31) — Tax Provision: 1509000000.00
CVS.TO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.26
CVS.TO balance_sheet (annual, 2022-12-31) — Total Assets: 228275000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Total Capitalization: 121945000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Total Debt: 70732000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 71769000000.00
CVS.TO income_statement (annual, 2022-12-31) — Total Expenses: 306177000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 156506000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 162642000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 87085000000.00
CVS.TO income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 7954000000.00
CVS.TO income_statement (annual, 2022-12-31) — Total Unusual Items: -8336000000.00
CVS.TO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -8336000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 458000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Treasury Stock: 31858000000.00
CVS.TO balance_sheet (annual, 2022-12-31) — Working Capital: -3788000000.00
CVS.TO income_statement (annual, 2023-12-31) — +Operating Expense: 39832000000.00
CVS.TO income_statement (annual, 2023-12-31) — +Total Revenue: 357776000000.00
CVS.TO balance_sheet (annual, 2023-12-31) — Accounts Payable: 14897000000.00
CVS.TO balance_sheet (annual, 2023-12-31) — Accounts Receivable: 15622000000.00
CVS.TO balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -20699000000.00
CVS.TO cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 152000000.00
CVS.TO balance_sheet (annual, 2023-12-31) — Assets Held For Sale Current: 0.00
CVS.TO balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 18582000000.00
CVS.TO income_statement (annual, 2023-12-31) — Basic Average Shares: 7057679697.00
CVS.TO income_statement (annual, 2023-12-31) — Basic EPS: 1.18
CVS.TO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 13305000000.00
CVS.TO balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 4571000000.00
CVS.TO cash_flow (annual, 2023-12-31) — Capital Expenditure: -3031000000.00
CVS.TO balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 17775000000.00
CVS.TO balance_sheet (annual, 2023-12-31) — Capital Stock: 48992000000.00
CVS.TO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 8196000000.00
CVS.TO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 11455000000.00
CVS.TO cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -3132000000.00
CVS.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 2683000000.00
CVS.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -20889000000.00
CVS.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 13426000000.00
CVS.TO cash_flow (annual, 2023-12-31) — Change In Account Payable: 3618000000.00
CVS.TO cash_flow (annual, 2023-12-31) — Change In Inventory: 1233000000.00
CVS.TO cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -510000000.00
CVS.TO cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 1540000000.00
CVS.TO cash_flow (annual, 2023-12-31) — Change In Payable: 4012000000.00
CVS.TO cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 4012000000.00
CVS.TO cash_flow (annual, 2023-12-31) — Change In Receivables: -6260000000.00
CVS.TO cash_flow (annual, 2023-12-31) — Change In Working Capital: 15000000.00
CVS.TO cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -6260000000.00
CVS.TO cash_flow (annual, 2023-12-31) — Changes In Cash: -4780000000.00
CVS.TO balance_sheet (annual, 2023-12-31) — Commercial Paper: 200000000.00
CVS.TO balance_sheet (annual, 2023-12-31) — Common Stock: 48992000000.00
CVS.TO cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -3132000000.00
CVS.TO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 76461000000.00
CVS.TO cash_flow (annual, 2023-12-31) — Common Stock Payments: -2012000000.00
CVS.TO income_statement (annual, 2023-12-31) — Cost Of Revenue: 303345000000.00
CVS.TO balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 23515000000.00
CVS.TO balance_sheet (annual, 2023-12-31) — Current Assets: 67858000000.00
CVS.TO balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 1741000000.00
CVS.TO balance_sheet (annual, 2023-12-31) — Current Debt: 2972000000.00
CVS.TO balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 4713000000.00
CVS.TO balance_sheet (annual, 2023-12-31) — Current Liabilities: 79189000000.00
CVS.TO cash_flow (annual, 2023-12-31) — Deferred Income Tax: -676000000.00
CVS.TO cash_flow (annual, 2023-12-31) — Deferred Tax: -676000000.00
CVS.TO balance_sheet (annual, 2023-12-31) — Defined Pension Benefit: 3250000000.00
CVS.TO cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 4366000000.00
CVS.TO cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 4366000000.00
CVS.TO income_statement (annual, 2023-12-31) — Diluted Average Shares: 7085141486.00
CVS.TO income_statement (annual, 2023-12-31) — Diluted EPS: 1.18